7-101163242-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_003378.4(VGF):ā€‹c.1602G>Cā€‹(p.Glu534Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000262 in 1,527,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 29)
Exomes š‘“: 0.000027 ( 0 hom. )

Consequence

VGF
NM_003378.4 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0160
Variant links:
Genes affected
VGF (HGNC:12684): (VGF nerve growth factor inducible) This gene is specifically expressed in a subpopulation of neuroendocrine cells, and is upregulated by nerve growth factor. The structural organization of this gene is similar to that of the rat gene, and both the translated and the untranslated regions show a high degree of sequence similarity to the rat gene. The encoded secretory protein also shares similarities with the secretogranin/chromogranin family, however, its exact function is not known. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14350551).
BS2
High AC in GnomAdExome4 at 37 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VGFNM_003378.4 linkuse as main transcriptc.1602G>C p.Glu534Asp missense_variant 2/2 ENST00000249330.3 NP_003369.2
VGFXM_005250561.6 linkuse as main transcriptc.1602G>C p.Glu534Asp missense_variant 2/2 XP_005250618.1
VGFXM_011516549.4 linkuse as main transcriptc.1602G>C p.Glu534Asp missense_variant 3/3 XP_011514851.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VGFENST00000249330.3 linkuse as main transcriptc.1602G>C p.Glu534Asp missense_variant 2/21 NM_003378.4 ENSP00000249330 P1
VGFENST00000445482.2 linkuse as main transcriptc.1602G>C p.Glu534Asp missense_variant 2/25 ENSP00000400884 P1

Frequencies

GnomAD3 genomes
AF:
0.0000199
AC:
3
AN:
150518
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000489
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000524
AC:
9
AN:
171838
Hom.:
0
AF XY:
0.0000107
AC XY:
1
AN XY:
93052
show subpopulations
Gnomad AFR exome
AF:
0.0000781
Gnomad AMR exome
AF:
0.000180
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000496
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000269
AC:
37
AN:
1376490
Hom.:
0
Cov.:
33
AF XY:
0.0000251
AC XY:
17
AN XY:
678226
show subpopulations
Gnomad4 AFR exome
AF:
0.0000339
Gnomad4 AMR exome
AF:
0.000158
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000265
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000279
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000199
AC:
3
AN:
150518
Hom.:
0
Cov.:
29
AF XY:
0.0000136
AC XY:
1
AN XY:
73414
show subpopulations
Gnomad4 AFR
AF:
0.0000489
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000148
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.0000334
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 12, 2023The c.1602G>C (p.E534D) alteration is located in exon 2 (coding exon 1) of the VGF gene. This alteration results from a G to C substitution at nucleotide position 1602, causing the glutamic acid (E) at amino acid position 534 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.091
T;T
Eigen
Uncertain
0.26
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.48
.;T
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.14
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N;N
MutationTaster
Benign
0.84
N;N
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.55
N;N
REVEL
Benign
0.095
Sift
Uncertain
0.029
D;D
Sift4G
Benign
0.22
T;T
Polyphen
0.99
D;D
Vest4
0.17
MutPred
0.063
Gain of helix (P = 0.2684);Gain of helix (P = 0.2684);
MVP
0.082
MPC
0.61
ClinPred
0.12
T
GERP RS
4.3
Varity_R
0.27
gMVP
0.066

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752218236; hg19: chr7-100806523; API